212 related articles for article (PubMed ID: 28734622)
1. Mild to moderate clozapine-induced gastrointestinal hypomotility should not require cessation of clozapine.
Every-Palmer S; Ellis PM; Flanagan RJ; Baptista T
Gen Hosp Psychiatry; 2017 Sep; 48():72-73. PubMed ID: 28734622
[No Abstract] [Full Text] [Related]
2. Response to: Mild to moderate clozapine-induced gastrointestinal hypomotility should not require cessation of clozapine.
West S; Rowbotham D; Xiong G; Kenedi C
Gen Hosp Psychiatry; 2017 Sep; 48():74. PubMed ID: 28662896
[No Abstract] [Full Text] [Related]
3. Clozapine-induced gastrointestinal hypomotility.
Vella-Brincat J; McKean A; Barclay M
Australas Psychiatry; 2011 Oct; 19(5):450-1. PubMed ID: 21995363
[No Abstract] [Full Text] [Related]
4. Focussing on the fundaments - assessing and treating Clozapine Induced Gastrointestinal Hypomotility.
Blackman G; Kapila A; Grosskopf CM; Dratcu L
Int J Psychiatry Clin Pract; 2020 Mar; 24(1):18-19. PubMed ID: 31910056
[No Abstract] [Full Text] [Related]
5. Clozapine-treated Patients Have Marked Gastrointestinal Hypomotility, the Probable Basis of Life-threatening Gastrointestinal Complications: A Cross Sectional Study.
Every-Palmer S; Nowitz M; Stanley J; Grant E; Huthwaite M; Dunn H; Ellis PM
EBioMedicine; 2016 Mar; 5():125-34. PubMed ID: 27077119
[TBL] [Abstract][Full Text] [Related]
6. Clozapine-Induced Gastrointestinal Hypomotility: A 22-Year Bi-National Pharmacovigilance Study of Serious or Fatal 'Slow Gut' Reactions, and Comparison with International Drug Safety Advice.
Every-Palmer S; Ellis PM
CNS Drugs; 2017 Aug; 31(8):699-709. PubMed ID: 28623627
[TBL] [Abstract][Full Text] [Related]
7. Clozapine and Gastrointestinal Hypomotility.
Cohen D
CNS Drugs; 2017 Dec; 31(12):1083-1091. PubMed ID: 29230675
[TBL] [Abstract][Full Text] [Related]
8. Reporting of clozapine-induced gastrointestinal hypomotility and factors associated with fatal outcomes in Canada: A pharmacovigilance database study.
Liu CL; Maruf AA; Bousman CA
Psychiatry Res; 2020 Aug; 290():113048. PubMed ID: 32474068
[TBL] [Abstract][Full Text] [Related]
9. Life-threatening clozapine-induced gastrointestinal hypomotility: an analysis of 102 cases.
Palmer SE; McLean RM; Ellis PM; Harrison-Woolrych M
J Clin Psychiatry; 2008 May; 69(5):759-68. PubMed ID: 18452342
[TBL] [Abstract][Full Text] [Related]
10. The Porirua Protocol in the Treatment of Clozapine-Induced Gastrointestinal Hypomotility and Constipation: A Pre- and Post-Treatment Study.
Every-Palmer S; Ellis PM; Nowitz M; Stanley J; Grant E; Huthwaite M; Dunn H
CNS Drugs; 2017 Jan; 31(1):75-85. PubMed ID: 27826741
[TBL] [Abstract][Full Text] [Related]
11. Clozapine-induced acute gastrointestinal necrosis: a case report.
Osterman MT; Foley C; Matthias I
J Med Case Rep; 2017 Sep; 11(1):270. PubMed ID: 28938913
[TBL] [Abstract][Full Text] [Related]
12. Effects of Clozapine on the Gut: Cross-Sectional Study of Delayed Gastric Emptying and Small and Large Intestinal Dysmotility.
Every-Palmer S; Inns SJ; Grant E; Ellis PM
CNS Drugs; 2019 Jan; 33(1):81-91. PubMed ID: 30456745
[TBL] [Abstract][Full Text] [Related]
13. Clozapine induced gastrointestinal hypomotility: A potentially life threatening adverse event. A review of the literature.
West S; Rowbotham D; Xiong G; Kenedi C
Gen Hosp Psychiatry; 2017 May; 46():32-37. PubMed ID: 28622812
[TBL] [Abstract][Full Text] [Related]
14. Spiking fevers with clozapine treatment.
Trémeau F; Clark SC; Printz D; Kegeles LS; Malaspina D
Clin Neuropharmacol; 1997 Apr; 20(2):168-70. PubMed ID: 9099470
[TBL] [Abstract][Full Text] [Related]
15. Medical management of patients on clozapine: A guide for internists.
Lundblad W; Azzam PN; Gopalan P; Ross CA
J Hosp Med; 2015 Aug; 10(8):537-43. PubMed ID: 25809850
[TBL] [Abstract][Full Text] [Related]
16. Cases of clozapine-induced gastrointestinal hypomotility in Europe: Outcomes and fatality risk factors based on EudraVigilance data.
Tyras S; Wierzchoń K; Jaroszewska A
Psychiatry Res; 2021 Jun; 300():113911. PubMed ID: 33827014
[No Abstract] [Full Text] [Related]
17. Colonic transit diagnostic test shows significant gastrointestinal hypomotility in clozapine-treated patients in comparison with subjects treated with other antipsychotics.
Baptista T; Carrizo E; Fernandez E; Connell L; Servigna M; Parra A; Quintero J; Pabón A; Sandia I; Uzcáteguid E; Serrano A; Pirela N; Villarreal L
Schizophr Res; 2015 Aug; 166(1-3):207-11. PubMed ID: 26032569
[TBL] [Abstract][Full Text] [Related]
18. [Clozapine screening: white bloodcell counts no longer sufficient].
Cohen D;
Tijdschr Psychiatr; 2010; 52(11):785-90. PubMed ID: 21064021
[TBL] [Abstract][Full Text] [Related]
19. [Clozapine use and abrupt smoking cessation; a potentially life-threatening combination].
Ruissen A; van Schaik AM; Beijnen JH
Tijdschr Psychiatr; 2009; 51(9):699-703. PubMed ID: 19760570
[TBL] [Abstract][Full Text] [Related]
20. Smoking cessation and clozapine side effects.
Oyewumi LK
Can J Psychiatry; 1998 Sep; 43(7):748. PubMed ID: 9773227
[No Abstract] [Full Text] [Related]
[Next] [New Search]
